Leonard E. Post - 24 Jan 2024 Form 3 Insider Report for CG Oncology, Inc. (CGON)

Reporting relationship: Director
Issuer ticker: CGON
Reported as of: 24 Jan 2024
Net transaction value: $0
SEC form: 3
Accepted by SEC: 24 Jan 2024, 20:56:02 UTC
Prior SEC filing: 20 Jun 2023
Next SEC filing: 18 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Corleen Roche, Attorney-in-Fact for Leonard Post

Key filing fact

Leonard E. Post filed Form 3 for CG Oncology, Inc. (CGON) on 24 Jan 2024.

Key facts

This page summarizes Leonard E. Post's Form 3 filing for CG Oncology, Inc. (CGON).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 24 Jan 2024, 20:56.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGON holding Derivative

No transaction description listed

CGON holding Derivative

No transaction description listed

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 2 footnotes

Footnote F1

The stock option is currently vested and exercisable.

Footnote F2

The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023.

SEC remarks

Exhibit 24 - Power of Attorney.